Abstract
In the course of screening for anti-dementia agents from natural products, two β-secretase (BACE1) inhibitors were isolated from the husk of pomegranate(Punica granatum) by activity-guided purification. They were identified as ellagic acid and punicalagin with IC50 values of 3.9 x10-6 and 4.1x10-7 M andKi values of 2.4x10-5 and 5.9x10-7 M, respectively. The compounds were non-competitive inhibitors with a substrate in the Dixon plot. Ellagic acid and punicalagin were less inhibitory to α-secretase (TACE) and other serine proteases such as chymotrypsin, trypsin, and elastase, thus indicating that they were relatively specific inhibitors of BACE1.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson, J. P., Barbour, R., Basi, G. S., Caccavelleo, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., Jacobson-Croak, K., Jewett, N., Keim, P., Knops, J., Lieberburg, I., Power, M., Tan, H., Tatsuno, G, Tung, J., Schenk, D., Seubert, P., Suomensaari, S. M., Wang, S., Walker, D., Zhao, J., McConlogue, L, and John, V., Purification and cloning of amyloid precursor protein ?-secretase from human brain.Nature, 402, 533–537 (1999).
Bieth, J., Spiess, G, and Camille, G. W., The synthesis and analytical use of a highly sensitive and convenient substrate of elastase.Biochem. Med., 11, 350–357 (1970).
Buxbaum, J. D., Liu, K.-N., Luo, Y, Slack, J. L, Stocking, K. L., Peschon, J. J., Johnson, R. S., Castner, B. J., Cerretti, D. P., and Black, R. A., Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor.J. Biol. Chem., 273, 27765–27767 (1998).
Chung, H., Ines, H. E., Almeda, S., and Goldberg, A. L, Purification ofEscherichia coli of a periplasmic protein that is potent inhibitor of pancreatic protease.J. Biol. Chem., 258, 11032–11038 (1983).
Dewachter, I. and Van Leuven, F., Secretases as targets for the treatment of Alzheimer’s disease: the prospects.Lancet Neurol., 1, 409–416 (2002).
Ghosh, A. K., Bilcer, G, Harwood, C, Kawahama, R., Shin, D., Hussain, K. A., Hong, L, Loy, J. A., Nguyen, C, Koelsch, G, Ermolieff, J., and Tang, J., Structure-based design: Structure- based design: potent inhibitors of human brain memapsin 2 (β-secretase).J. Med. Chem., 44, 2865–2868 (2001).
Ghosh, A. K., Shin, D., Downs, B., Koelsch, G., Lin, X., Ermolieff, J., and Tang, J., Design of potent inhibitors for human brain memapsin 2 (β-secretase).J. Am. Chem. Soc, 122, 3522–3523 (2000).
Glenner, G. G and Wong, W., Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.Biochem. Biophys. Res. Commun., 120, 885–890 (1984).
Hubert, F., Gaertner, J., Antonie, J., and Puigserver, A. J., Increased activity and stability of polyethyleneglycol-modified trypsin.Enzyme Microb. Technol., 14, 150–155 (1992).
Jeon, S.-Y, Bae, K., Seong, Y.-H., and Song, K.-S., Green tea catechins as BACE1 (β-secretase) inhibitor.Bioorg. Med. Chem. Lett., 13, 3905–3908 (2003).
Miyamoto, M., Matsui, J., Fukumoto, H., and Tarui, N., Preparation of 2-[2-amino- or 2-(N-heterocyclyl)ethyl]-6-(4- biphenylylmethoxy) tetralin derivatives as β-secretase inhibitors.PCTInt. Appl., WO 087293 (2001).
Moharram, F. A., Marzouk, M. S., El-Toumy, A. A, and Ahmed, A. A. E., Polyphenols of Melaleuca quinquenervia leaves-Pharmacological Studies of Grandinin.Phytother. Res., 17, 767–773 (2003).
Ramakrishna, N. V. S., Kumar, E. K. S. V., Kulkarni, A. S., Jain, A. K., Bhat, R. G, Parikh, S., Quadras, A., Deuskar, N., and Kalakoti, B. S., Screening of natural products for new leads as inhibitors of β-amyloid production: Latifolin fromDalbergia sissoo.Ind. J. Chem., 40B, 539–540 (2001).
Schmidt, B. and Siegler, A., Aspartic protease involved in Alzheimer’s disease.Highlights in Bioorg., 262–276 (2004).
Selkoe, D. J., Alzheimer’s disease: genes, proteins, and therapy.Physiol. Rev., 81, 741–766 (2001).
Sisodia, S. S. and Price, D. L., Role of the β-amyloid protein in Alzheimer’s disease.FASEB J., 9, 366–370 (1995).
Tanaka, T., Nonaka G., and Nishioka, I., Tannins and related compounds. XL. Revision of the structures of punicalagin and punicalagin, and isolation and characterization of 2-O-galloylpunicalin from the bark ofPunica granatum L.Chem. Pharm. Bull. 34, 650–655 (1986).
Vassar, R., β-Secretase as a drug target for Alzheimer’s disease.Adv. DrugDeliv. Rev., 54,1589–1602 (2002).
Vassar, R., Bennett, B. D., Babu-Khan, S., Khan, S., Mendiaz, A., Denis, P., Teplow, D. B, Ross, S., Amarante, P., Loeloff, R., Luo, Y, Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G., and Citron, M., Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE1.Science, 286, 735–741 (1999).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kwak, HM., Jeon, SY., Sohng, BH. et al. β-Secretase(BACE1) inhibitors from pomegranate (Punica granatum) husk. Arch Pharm Res 28, 1328–1332 (2005). https://doi.org/10.1007/BF02977896
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02977896